IONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INC

IONIS PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

52.330.00 0.00%
The 22 analysts offering 1 year price forecasts for ISI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 25 analysts giving stock ratings to ISI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ISI EPS for the last quarter is −0.88 CHF despite the estimation of −0.93 CHF. In the next quarter EPS is expected to reach −0.89 CHF. Track more of IONIS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter IONIS PHARMACEUTICALS INC revenue is expected to reach ‪134.35 M‬ CHF. Check out IONIS PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, ISI price target is 52.33 CHF with a max estimate of 74.55 CHF and a min estimate of 30.00 CHF. Check if this forecast comes true in a year, meanwhile watch IONIS PHARMACEUTICALS INC stock price chart and keep track of the current situation with ISI news and stock market news.
We've gathered opinions of 25 analysts rating ISI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.